Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection

Journal of Nephrology

Volumn 19, Issue 3, 2006, Pages 327-333

  Siagris, Dimitrios ^a,b   Christofidou, M ^a   Triga, K ^a   Pagoni, N ^a   Theocharis, G J ^a   Goumenos, D ^a   Lekkou, A ^a   Thomopoulos, K ^a   Tsamandas, A C ^a   Vlachojannis, J ^a   Labropoulou Karatza, C ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIGEN; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; DNA DETERMINATION; HEMODIALYSIS PATIENT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; LIVER BIOPSY; LIVER CELL; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; ADULT; AGED; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; FEMALE; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY; SEROLOGY; VIRUS LOAD;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C, CHRONIC; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; SEROLOGIC TESTS; VIRAL LOAD;

EID: 33749043676     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Natov SN, Pereira BJ. Hepatitis C infection in patients on dialysis. Semin Dial 1994; 7: 360-8.
2. Hepatitis B in retreat from dialysis units in United Kingdom in 1973. Public Health Laboratory Service survey. Br Med J 1976; 26: 1579-81.
3. Alter MJ, Favero MS, Moyer LA, Bland LA. National Surveillance of Dialysis-Associated Diseases in the United States, 1989. Trans Am Soc Artif Intern Organs 1991; 37: 97-109.
4. Miller ER, Alter MJ, Tokars JI. Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 1999; 33: 356-60.
5. Moyer LA, Alter MJ, Favero MS. Hemodialysis-associated hepatitis B: revised recommendations for serologic screening. Semin Dial 1990; 3: 201-4.
6. Pontisso P, Gerotto M, Benvegnu L, Chemello L, Alberti A. Coinfection by hepatitis B virus and hepatitis C virus. Antivir Ther 1998; 3: 137-42.
7. Gonzalez S, Navas S, Madejon A, Bartoleme J, Castillo I, Moraleda G, Moartin J, Mariott E, Herrero M, Carreno V. Hepatitis B virus and D virus genomes in hepatitis B surface antigen negative patients with chronic hepatitis C. J Med Virol 1995; 45: 168-73.
8. Zignego AL, Fontana R, Pulti S, Barbagli S, Monti M, Careccia G, Gianneli F, Giannini C, Buzzelli G, Rossana M, Bonino F, Gentilini P. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic infection. J Med Virol 1997; 51: 313-8.
9. EASL Jury. EASL International consensus conference on hepatitis B, 13-14 September 2002, Geneva, Switzerland, consensus statement. J Hepatol 2003; 38: 533-40.
10. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimani R, Esteban R, Guardia J. Role of hepatitis B, C and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001; 34: 401-10.
11. Shih CM, Lo SJ, Miyamura T, Chen SY, Lee YH. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993; 67: 5823-32.
12. Hu K-Q. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002; 9: 243-57.
13. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RNM, Phillips MJ, Portmann BG, Poulsen H, Sheuer PJ, Shmid M, Thaler H. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
14. Wolf PL, Williams D, Coplon N, Coulson AS. Low aspartate transaminase activity in serum of patients undergoing chronic hemodialysis. Clin Chem 1972; 18: 567-8.
15. Okuda M, Hayashi H, Yokozeki K, Irie Y. Destruction of hepatitis C virus particles by hemodialysis. Lancet 1996; 347: 909-10.
16. Pesanti EL. Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 2001; 15: 813-32.
17. Descamps-Latscha B, Chatenoud L. T cells and B cells in chronic renal failure [review]. Semin Nephrol 1994; 16: 183-91.
18. Descamps-Latscha B, Herbelin A, Nguyen AT, Zingraff J, Jungers P, Chatenoud L. The immune system in end-stage renal disease. Semin Nephrol 1994; 14: 253-60.
19. Kruger S, Seyfarth M, Sack K, Kreft B. Defective immune response to tetanus toxoid in hemodialysis patients and its association with diptheria vaccination. Vaccine 1999; 17: 1145-50.
20. Meuer SC, Hauer M, Kurz P, Meyer zum Buschenfelde KH, Kohler H. Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest 1987; 80: 743-9.
21. Fabrizi F, Martin P. Hepatitis B virus infection in dialysis patients [review]. Am J Nephrol 2000; 20: 1-11.
22. Buti M, Viladomiu L, Jardi R, Olmos A, Rodriguez JA, Bartolome J, Esteban R, Guardia J. Long-term immunologenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol 1992; 12: 144-7.
23. Kreutz C. Molecular, immunological and clinical properties of mutated hepatitis B viruses. J Cell Mol Med 2002; 6: 113-43.
24. Blum HE, Liang TJ, Galum E, Wands JR. Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991; 14: 56-63.
25. Preisler Adams S, Schlayer HJ, Peters T, Hettler F, Gerok W, Rasenack J. Sequence analysis of hepatitis B virus DNA in immunologically negative infection. Arch Virol 1993; 133: 385-96.
26. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325-9.
27. Besisic F, Karaca C, Akyüz F, Horosanli S, Önel D, Badur S, Sever MS, Danalioglu A, Demir K, Kaymakoglu S, Cakaloglu Y, Ökten A. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J Hepatol 2003; 38: 506-10.
28. Fabrizi F, Messa PG, Lunghi G, Aucella F, Bisegna S, Mangano S, Villa M, Barbisoni F, Rusconi E, Martin P. Occult hepatitis B virus infection in dialysis patients: a multicentre survey. Aliment Pharmacol Ther 2005; 21: 1341-7.
29. Peres AA, Dias EA, Chesky M, Alvares-da-Silva, Jobim LF, Goncalves LF, Manfro RC. Occult hepatitis B in renal transplant patients. Transpl Infect Dis 2005; 7: 51-56.
30. Kazemi-Shirazi L, Petermann D, Müller C. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C. J Hepatol 2000; 33: 785-90.
31. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341: 22-6.
32. Uchida T, Kaneita Y, Gotoh K, Kanagawa H, Kouyama Y, Kawanishi T, Mima S. Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis C virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection. J Med Virol 1997; 52: 399-405.
33. Georgiadou SP, Zachou K, Rigopoulou E, Liaskos C, Mina P, Gerovasilis F, Makri E, Dalekos GN. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases. J Viral Hepat 2004; 11: 358-65.
34. Porchon C, Kremsdorf D, Pol S, Lunel-Fabiani F, Driss F, Opolon P, Berthelot P, Brechot C. Serum hepatitis C virus RNA and hepatitis B virus DNA in non-A, non-B post-transfusional and sporadic chronic hepatitis. J Hepatol 1992; 16: 184-9.
35. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 1529-33.
36. Nalpas B, Pourcel C, Felman G, Housset C, Tiollais P, Brechot C, Berthelot P, Farza H. Chronic alcohol intoxication decreases the serum level of hepatitis B antigen in transgenic mice. J Hepatol 1992; 15: 118-24.
37. Fabrizi F, Lunghi G, Martin P. Hepatitis B virus infection in hemodialysis: recent discoveries. J Nephrol 2002; 15: 463-8.
38. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis surface antigen: clinically significant or purely "occult"? Hepatology 2001; 34: 194-203.
39. Minuk GY, Sun DF, Greenberg R, Zhang M, Hawkins K, Uhanova J, Gutkin A, Bemstein K, Giulini A, Osiowy C. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 2004; 40: 1072-7.
40. Fukuda R, Ishimura N, Niigaki M, Hamamoto S, Satoh S, Tanaka S, Kushiyama Y, Uchida Y, Ihihara S, Akagi S, Watanabe M, Kinoshita Y. Serologically silent hepatitis B coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 1999; 58: 201-7.
41. Rodriguez-Inigo E, Mariscal L, Bartolome J, Castillo I, Navacerrada C, Ortiz-Movilla N, Pardo M, Carreno V. Distribution of hepatitis B virus in the liver of chronic hepatitis C patients with occult hepatitis B infection. J Med Virol 2003; 70: 571-80.